SYRE
#1066
Spyre Therapeutics, Inc. - Common Stock
87.0 5 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.64%
Variación mensual
-10.72%
Variación en los últimos 6 meses
+116.87%
Cambio anual
+264.07%
Cierres anteriores
88.5 0
Open
87.0 5
Mínimo
87.0 5
Máximo
87.0 5
Volumen
155
Financials
- Market Capitalization 7.68 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-44.84
Relación precio/flujo de caja
411.15
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1018 |  APGE Apogee Therapeutics, Inc. - Common Stock | 135.07 USD | -0.01% | +0.12% | +0.61% | +152.04% | 8.40 B USD | ||
| 1037 |  IMVT Immunovant, Inc. - Common Stock | 39.49 USD | -1.03% | -9.43% | +0.92% | +105.57% | 8.16 B USD | ||
| 1097 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 105.42 USD | +0.65% | -5.21% | +5.16% | -4.43% | 7.26 B USD | ||
| 1126 |  SRRK Scholar Rock Holding Corporation - Common Stock | 56.10 USD | +0.38% | -6.50% | +20.96% | +86.88% | 6.83 B USD |